PO26 Amaryllidaceae Species: Source of Cytotoxic Alkaloids in Cancer of Epidemiological Relevance
DOI:
https://doi.org/10.3407/trsdvx73Keywords:
Cancer, cytotoxic activity, alkaloids, Amaryllidaceae speciesAbstract
Cancer is a leading cause of death and a serious impediment to increasing life expectancy worldwide, with breast, prostate, stomach, lung, and uterine cancers being the most common in terms of incidence and mortality. Therefore, the objective of this research was to identify novel molecules for potential chemotherapeutic treatment of epidemiologically relevant cancers. We determined the cytotoxic activity of chemically characterized alkaloid fractions from ten introduced, native, and endemic Amaryllidaceae species in Colombia against gastric, lung, breast, prostate, and uterine cancer cell lines.
References
[1] FERLAY, J., et al. (2021). Cancer Statistics for the Year 2020: An Overview. Int J Cancer 10.1002/ijc.33588. [DOI]
[2] ARNOLD, M., et al. (2022). Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040. Breast 66: 15-23. [DOI]
[3] LU, J. J. y WANG, Y. T. (2020). Identification of Anti-Cancer Compounds from Natural Products. Chin J Nat Med 18(7): 481-482. [DOI]
[4] NEWMAN, D. J. y CRAGG, G. M. (2020). Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod 83(3): 770-803. [DOI]
[5] HOWES, M. R. (2018). The Evolution of Anticancer Drug Discovery from Plants. Lancet Oncol 19(3): 293-294. [DOI]
[6] NAIR, J. J., et al. Chapter 3 - Cytotoxic Alkaloid Constituents of the Amaryllidaceae. In: ATTA UR, R. (ed.). Studies in Natural Products Chemistry. Elsevier, (2016). p. 107-156. [DOI]
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Lina Marcela TRUJILLO CHACÓN, Edison OSORIO DURANGO, Yesin Hawer Leiva Cuenca, Dagoberto CASTRO
This work is licensed under a Creative Commons Attribution 4.0 International License.
License Terms
The Creative Commons Attribution License (CC BY 4.0) allows users to copy, distribute and transmit an article and adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity.
How to Cite
